Drug Trial Radar · NCT05591222
Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus
Last checked: Nov 19, 2026Latest source record: May 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
72
Actual
Start
Dec 29, 2022
Primary completion
May 8, 2025
Study completion May 8, 2025
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Oct 24, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 2, double-blind, randomized, placebo-controlled parallel-group study to evaluate the efficacy and safety of daxdilimab in participants with moderate-to-severe active primary Discoid Lupus Erythematosus (DLE) refractory to standard of care.
Conditions
- Discoid Lupus Erythematosus
Interventions
PlaceboDrug
Placebo will be administered subcutaneously as two injections for each dose.
DaxdilimabDrug
Daxdilimab will be administered subcutaneously as two injections for each dose.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change in Cutaneous Lupus Erythematosus Disease and Severity Index-Activity (CLASI-A) Score from Baseline to Week 24Time frame: Baseline to Week 24
Locations
68 sites in 11 countries. Site status is shown where the registry gives one.
Arkansas Research Trials
North Little Rock, Arkansas
Wallace Medical Group
Beverly Hills, California
The Center for Dermatology Clinical Research
Fremont, California
Clinical Science Institute
Santa Monica, California
Miami Dermatology & Laser Research
Miami, Florida
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana
Detroit Clinical Research Center, PC
Farmington Hills, Michigan
Michigan Dermatology Institute
Waterford, Michigan
Minnesota Clinical Study Center
New Brighton, Minnesota
MediSearch Clinical Trials
Saint Joseph, Missouri
Forest Hills Dermatology
Forest Hills, New York
Ohio State University
Columbus, Ohio
Wright State Physicians
Fairborn, Ohio
Paddington Testing Company, Inc.
Philadelphia, Pennsylvania
Autoimmune Skin Diseases Unit, Dept. of Dermatology
Philadelphia, Pennsylvania
Center for Clinical Studies (Cypress)
Houston, Texas
CIPREC
Ciudad Autonoma Buenos Aires, Argentina
Fundacion Scherbovsky
Mendoza, Mendoza Province, Argentina
IPITEC Instituto de Pesquisa Inovação Tecnológica
São Paulo, Brazil
HUWC - UFC - Hospital Universitário Walter Cantídio - Universidade Federal do Ceará
Fortaleza, Ceará, Brazil
Hospital Universitário Evangélico Mackenzie
Água Verde, Paraná, Brazil
Fundação Faculdade Regional de Medicina de São José do Rio Preto, CIP - Centro Integrado de Pesquisa
Sao Jose Rio, Preto Sao Paulo, Brazil
Complexo Hospitalar de Niterói
Niterói, Rio Do Janeiro, Brazil
Instituto Brasil de Pesquisa Clínica-IBPCLIN S/A
Rio de Janeiro, Rio Do Janeiro, Brazil
Fundação Universidade de Caxias do Sul - Instituto de Pesquisas em Saúde da Universidade de Caxias do Sul
Caxias do Sul, Rio Grande do Sul, Brazil
Hospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, Brazil
Irmandade da Santa Casa de Misericórdia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
LMK Serviços Médicos S/S
Porto Alegre, Rio Grande do Sul, Brazil
Universidade Estadual de Campinas
Campinas, São Paulo, Brazil
Hospital Christovão da Gama - Centro de Estudos
Santo André, São Paulo, Brazil
Centro Multidisciplinar de Estudos Clinicos
São Bernardo do Campo, São Paulo, Brazil
IMC - Instituto de Moléstias Cardiovasculares Tatuí
Tatuí, São Paulo, Brazil
DCC 'Sveti Georgi' EOOD
Haskovo, Bulgaria
Ambulatory for specialized medical care - individual practice for specialized medical care - skin and venereal diseases
Sofia, Bulgaria
DCC "Alexandrovska" EOOD
Sofia, Bulgaria
Medical Center Eurohealth EOOD
Sofia, Bulgaria
Alberta DermaSurgery Centre
Edmonton, Alberta, Canada
Brunswick Dermatology Center
Fredericton, New Brunswick, Canada
DermEffects
London, Ontario, Canada
North York Research, Inc
Toronto, Ontario, Canada
Showing 40 of 68 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.